Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)
NCT03790332· Phase 1/2· Pharmacyclics LLC.· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error